REGN logo

REGN Accounts payable

annual accounts payable:

$789.50M+$182.90M(+30.15%)
December 31, 2024

Summary

  • As of today (June 29, 2025), REGN annual accounts payable is $789.50 million, with the most recent change of +$182.90 million (+30.15%) on December 31, 2024.
  • During the last 3 years, REGN annual accounts payable has risen by +$225.50 million (+39.98%).
  • REGN annual accounts payable is now at all-time high.

Performance

REGN Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

quarterly accounts payable:

$705.50M-$84.00M(-10.64%)
March 31, 2025

Summary

  • As of today (June 29, 2025), REGN quarterly accounts payable is $705.50 million, with the most recent change of -$84.00 million (-10.64%) on March 31, 2025.
  • Over the past year, REGN quarterly accounts payable has increased by +$34.20 million (+5.09%).
  • REGN quarterly accounts payable is now -10.64% below its all-time high of $789.50 million, reached on December 31, 2024.

Performance

REGN quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

REGN Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+30.1%+5.1%
3 y3 years+40.0%+50.0%
5 y5 years+88.8%+102.8%

REGN Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+40.0%-10.6%+50.0%
5 y5-yearat high+88.8%-10.6%+102.8%
alltimeall timeat high>+9999.0%-10.6%>+9999.0%

REGN Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$705.50M(-10.6%)
Dec 2024
$789.50M(+30.2%)
$789.50M(+58.8%)
Sep 2024
-
$497.30M(-11.5%)
Jun 2024
-
$561.70M(-16.3%)
Mar 2024
-
$671.30M(+10.7%)
Dec 2023
$606.60M(+3.0%)
$606.60M(+13.0%)
Sep 2023
-
$536.60M(-2.0%)
Jun 2023
-
$547.30M(-8.7%)
Mar 2023
-
$599.50M(+1.7%)
Dec 2022
$589.20M(+4.5%)
$589.20M(+10.0%)
Sep 2022
-
$535.60M(+0.3%)
Jun 2022
-
$534.20M(+13.6%)
Mar 2022
-
$470.30M(-16.6%)
Dec 2021
$564.00M(+18.6%)
$564.00M(+32.1%)
Sep 2021
-
$427.00M(-10.3%)
Jun 2021
-
$476.00M(-12.3%)
Mar 2021
-
$542.90M(+14.2%)
Dec 2020
$475.50M(+13.7%)
$475.50M(+7.3%)
Sep 2020
-
$443.10M(+16.6%)
Jun 2020
-
$380.10M(+9.3%)
Mar 2020
-
$347.80M(-16.8%)
Dec 2019
$418.10M(+91.6%)
$418.10M(+24.6%)
Sep 2019
-
$335.60M(+37.5%)
Jun 2019
-
$244.00M(+1.8%)
Mar 2019
-
$239.60M(+9.8%)
Dec 2018
$218.20M(+22.4%)
$218.20M(+26.6%)
Sep 2018
-
$172.36M(+0.3%)
Jun 2018
-
$171.91M(-17.2%)
Mar 2018
-
$207.61M(+16.5%)
Dec 2017
$178.20M(+32.0%)
$178.20M(+15.8%)
Sep 2017
-
$153.95M(+1.7%)
Jun 2017
-
$151.37M(+6.7%)
Mar 2017
-
$141.80M(+5.1%)
Dec 2016
$134.98M(-4.2%)
$134.98M(+8.4%)
Sep 2016
-
$124.50M(+22.4%)
Jun 2016
-
$101.72M(-15.7%)
Mar 2016
-
$120.59M(-14.4%)
Dec 2015
$140.96M(+41.7%)
$140.96M(+31.8%)
Sep 2015
-
$106.92M(-17.8%)
Jun 2015
-
$130.02M(+43.5%)
Mar 2015
-
$90.60M(-9.0%)
Dec 2014
$99.51M(+60.7%)
$99.51M(+110.2%)
Sep 2014
-
$47.34M(+0.2%)
Jun 2014
-
$47.23M(+44.5%)
Mar 2014
-
$32.69M(-47.2%)
Dec 2013
$61.94M(+59.1%)
$61.94M(+98.6%)
Sep 2013
-
$31.19M(+27.8%)
Jun 2013
-
$24.42M(-1.3%)
Mar 2013
-
$24.73M(-36.5%)
Dec 2012
$38.93M(+40.4%)
$38.93M(+77.4%)
Sep 2012
-
$21.94M(-14.5%)
Jun 2012
-
$25.67M(+1.1%)
Mar 2012
-
$25.39M(-8.5%)
Dec 2011
$27.74M(+77.9%)
$27.74M(+60.2%)
Sep 2011
-
$17.31M(-33.3%)
Jun 2011
-
$25.95M(+60.8%)
Mar 2011
-
$16.15M(+3.6%)
Dec 2010
$15.59M(+148.7%)
$15.59M(+19.6%)
Jun 2009
-
$13.03M(-26.7%)
Mar 2009
-
$17.78M(+183.6%)
Dec 2008
$6.27M(-22.9%)
$6.27M(-52.5%)
Sep 2008
-
$13.19M(+26.4%)
Jun 2008
-
$10.44M(+10.1%)
Mar 2008
-
$9.47M(+16.6%)
Dec 2007
$8.13M
$8.13M(+52.5%)
DateAnnualQuarterly
Sep 2007
-
$5.33M(-71.3%)
Jun 2007
-
$18.55M(+286.0%)
Mar 2007
-
$4.80M(-77.6%)
Dec 2006
$21.47M(+410.8%)
$21.47M(+487.1%)
Sep 2006
-
$3.66M(+28.8%)
Jun 2006
-
$2.84M(-24.4%)
Mar 2006
-
$3.76M(-10.6%)
Dec 2005
$4.20M(-77.7%)
$4.20M(-79.6%)
Sep 2005
-
$20.60M(+20.9%)
Jun 2005
-
$17.04M(-2.4%)
Mar 2005
-
$17.47M(-7.4%)
Dec 2004
$18.87M(-0.3%)
$18.87M(-7.0%)
Sep 2004
-
$20.28M(+28.8%)
Jun 2004
-
$15.74M(-16.9%)
Mar 2004
-
$18.95M(+0.1%)
Dec 2003
$18.93M(-37.5%)
$18.93M(-9.7%)
Sep 2003
-
$20.97M(+49.3%)
Jun 2003
-
$14.04M(-44.3%)
Mar 2003
-
$25.20M(-16.9%)
Dec 2002
$30.31M(+104.4%)
$30.31M(+24.3%)
Sep 2002
-
$24.38M(+44.0%)
Jun 2002
-
$16.93M(-0.8%)
Mar 2002
-
$17.07M(+15.1%)
Dec 2001
$14.83M(+57.0%)
$14.83M(+46.5%)
Sep 2001
-
$10.12M(+21.9%)
Jun 2001
-
$8.30M(-11.7%)
Mar 2001
-
$9.40M(-0.4%)
Dec 2000
$9.45M(+43.1%)
$9.45M(+17.8%)
Sep 2000
-
$8.02M(+5.0%)
Jun 2000
-
$7.64M(+10.3%)
Mar 2000
-
$6.92M(+4.9%)
Dec 1999
$6.60M(+17.9%)
$6.60M(+46.7%)
Sep 1999
-
$4.50M(-8.2%)
Jun 1999
-
$4.90M(-18.3%)
Mar 1999
-
$6.00M(+7.1%)
Dec 1998
$5.60M(+19.1%)
$5.60M(+27.3%)
Sep 1998
-
$4.40M(-13.7%)
Jun 1998
-
$5.10M(+37.8%)
Mar 1998
-
$3.70M(-21.3%)
Dec 1997
$4.70M(+6.8%)
$4.70M(+14.6%)
Sep 1997
-
$4.10M(-19.6%)
Jun 1997
-
$5.10M(+50.0%)
Mar 1997
-
$3.40M(-22.7%)
Dec 1996
$4.40M(-30.2%)
$4.40M(+4.8%)
Sep 1996
-
$4.20M(0.0%)
Jun 1996
-
$4.20M(-2.3%)
Mar 1996
-
$4.30M(-31.7%)
Dec 1995
$6.30M(+26.0%)
$6.30M(+46.5%)
Sep 1995
-
$4.30M(-6.5%)
Jun 1995
-
$4.60M(+24.3%)
Mar 1995
-
$3.70M(-26.0%)
Dec 1994
$5.00M(-51.5%)
$5.00M(+19.0%)
Sep 1994
-
$4.20M(-34.4%)
Jun 1994
-
$6.40M(+6.7%)
Mar 1994
-
$6.00M(-41.7%)
Dec 1993
$10.30M(+312.0%)
$10.30M(+53.7%)
Sep 1993
-
$6.70M(+28.8%)
Jun 1993
-
$5.20M(+73.3%)
Mar 1993
-
$3.00M(+20.0%)
Dec 1992
$2.50M(+56.3%)
$2.50M(+31.6%)
Jun 1992
-
$1.90M(0.0%)
Mar 1992
-
$1.90M(+18.8%)
Dec 1991
$1.60M
$1.60M(+220.0%)
Sep 1991
-
$500.00K(-37.5%)
Jun 1991
-
$800.00K

FAQ

  • What is Regeneron Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual accounts payable year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly accounts payable year-on-year change?

What is Regeneron Pharmaceuticals annual accounts payable?

The current annual accounts payable of REGN is $789.50M

What is the all time high annual accounts payable for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual accounts payable is $789.50M

What is Regeneron Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, REGN annual accounts payable has changed by +$182.90M (+30.15%)

What is Regeneron Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of REGN is $705.50M

What is the all time high quarterly accounts payable for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly accounts payable is $789.50M

What is Regeneron Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, REGN quarterly accounts payable has changed by +$34.20M (+5.09%)
On this page